Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

08/11/2019 06:15

Nov 8 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Sep 30, 2019        Sep 30, 2018      Dec 31, 2019 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            708 mln             532 mln            1.76     
                 (+32.9 pct)         (-12.1 pct)      (+135.9 pct) 
  Operating     loss 534 mln        loss 835 mln      loss 84 mln  
  Recurring     loss 527 mln        loss 818 mln      loss 82 mln  
  Net           loss 531 mln        loss 844 mln      loss 106 mln 
  EPS          loss 25.94 yen      loss 41.47 yen    loss 5.13 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T